28 July 2015
Deltex Medical Group plc
("Deltex Medical" or "the Company")
Additional Listing
Deltex Medical Group plc was notified on 24 July 2015 that certain former employees have acquired 75,000 ordinary shares of 1p each, as the result of the exercise of options awarded under the Company's 2013 Enterprise Management Incentive Schemes.
Accordingly, application has been made for these shares to be admitted to trading on AIM. The ordinary shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 3 August 2015.
Following this, the total number of voting rights in issue will be 219,584,986.
For further information, please contact:-
Deltex Medical Group plc |
01243 774 837 investorinfo@deltexmedical.com |
Nigel Keen, Chairman |
|
Ewan Phillips, Chief Executive |
|
Paul Mitchell, Finance Director |
|
Barry Curtis, Company Secretary |
|
|
|
Nominated Adviser & Broker |
|
Arden Partners plc |
020 7614 5900 |
Chris Hardie |
|
Joint Broker Zeus Capital Limited Dominic Wilson John Goold
|
020 7533 7727
|
Financial Public Relations |
|
Newgate |
020 7653 9850 |
Tim Thompson |
|
Robyn McConnachie Ed Treadwell |
|